451 – 460 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Genetic aspects and research development in haemostasis
(
- Contribution to journal › Article
-
Mark
Surgical evaluation of a recombinant factorVIII prepared using a plasma/albumin-free method: Efficacy and safety of Advate in previously treated patients
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis
(
- Contribution to journal › Article
-
Mark
Transglutaminase and peptidylarginine deiminase in the pathogenesis of autoimmune diseases
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.
(
- Contribution to journal › Scientific review
-
Mark
High purity, double virus-inactivated VWF/FVIII concentrate in long term prophylaxis of von Willebrand disease - experience from prospective clinical trials and German post-licensure surveillance
2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.12-12(
- Contribution to journal › Published meeting abstract
-
Mark
Protecting the joints of mice and men.
(
- Contribution to journal › Article
-
Mark
Prophylaxis in von Willebrand disease.
(
- Contribution to journal › Article
-
Mark
Standardization and clinical utility of thrombin-generation assays.
(
- Contribution to journal › Article
-
Mark
N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
(
- Contribution to journal › Article